|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
173,970,000 |
Market
Cap: |
4.96(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$13.29 - $43.89 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile BridegeBio Pharma identifies and improves medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Co.'s pipeline are: Acoramidis/AG10/BBP-265, a small molecule transthyretin (TTR) stabilizer for the treatment of TTR amyloidosis; Infigratinib/BBP-831, an oral FGFR1-3 selective tyrosine kinase inhibitor for the treatment of achondroplasia; BBP-631, a preclinical adeno-associated virus gene transfer for the treatment of congenital adrenal hyperplasia; and Encaleret, a small molecule antagonist of the calcium sensing receptor for the treatment of Autosomal Dominant Hypocalcemia Type 1.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
5,415 |
192,897 |
1,845,608 |
2,886,602 |
Total Sell Value |
$195,041 |
$7,018,061 |
$62,779,686 |
$73,415,196 |
Total People Sold |
2 |
5 |
6 |
6 |
Total Sell Transactions |
2 |
10 |
16 |
29 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mccormick Frank |
Director |
|
2023-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,200,065 |
|
44% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-02-17 |
4 |
AS |
$12.65 |
$225,066 |
D/D |
(17,717) |
219,529 |
|
30% |
|
Kumar Neil |
CEO and President |
|
2023-02-17 |
4 |
AS |
$12.70 |
$569,073 |
D/D |
(44,798) |
4,813,197 |
|
30% |
|
Scheller Richard H |
Director |
|
2023-02-16 |
4 |
D |
$12.64 |
$16,483 |
D/D |
(1,304) |
53,822 |
|
- |
|
Scheller Richard H |
Director |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,196 |
55,126 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-02-16 |
4 |
D |
$12.64 |
$125,262 |
D/D |
(9,910) |
237,246 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,627 |
247,156 |
|
- |
|
Homcy Charles J |
Director |
|
2023-02-16 |
4 |
D |
$12.64 |
$19,390 |
D/D |
(1,534) |
1,218,368 |
|
- |
|
Homcy Charles J |
Director |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,219,902 |
|
- |
|
Kumar Neil |
CEO and President |
|
2023-02-16 |
4 |
D |
$12.64 |
$302,197 |
D/D |
(23,908) |
4,857,995 |
|
- |
|
Kumar Neil |
CEO and President |
|
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,706 |
4,881,903 |
|
- |
|
Kumar Neil |
CEO and President |
|
2023-02-03 |
4 |
AS |
$11.01 |
$1,320,696 |
I/I |
(120,000) |
1,372,722 |
|
56% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2023-02-03 |
4 |
AS |
$11.01 |
$671,922 |
D/D |
(61,040) |
219,184 |
|
56% |
|
Kumar Neil |
CEO and President |
|
2022-12-21 |
4 |
S |
$0.00 |
$0 |
I/I |
(200,000) |
995,686 |
|
-74% |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2022-11-17 |
4 |
S |
$9.40 |
$184,985 |
D/D |
(19,678) |
341,264 |
|
-72% |
|
Kumar Neil |
CEO and President |
|
2022-11-17 |
4 |
S |
$9.40 |
$325,606 |
D/D |
(34,640) |
4,813,197 |
|
-72% |
|
Scheller Richard H |
Director |
|
2022-11-16 |
4 |
D |
$9.64 |
$10,662 |
D/D |
(1,106) |
51,930 |
|
- |
|
Scheller Richard H |
Director |
|
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,196 |
53,036 |
|
- |
|
Homcy Charles J |
Director |
|
2022-11-16 |
4 |
D |
$9.64 |
$12,542 |
D/D |
(1,301) |
1,214,251 |
|
- |
|
Homcy Charles J |
Director |
|
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,215,552 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2022-11-16 |
4 |
D |
$9.64 |
$104,006 |
D/D |
(10,789) |
360,942 |
|
- |
|
Stephenson Brian C |
Secretary, Treasurer & CFO |
|
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,467 |
371,731 |
|
- |
|
Kumar Neil |
CEO and President |
|
2022-11-16 |
4 |
D |
$9.64 |
$328,396 |
D/D |
(34,066) |
4,847,837 |
|
- |
|
Kumar Neil |
CEO and President |
|
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,706 |
4,881,903 |
|
- |
|
Homcy Charles J |
Director |
|
2022-08-16 |
4 |
D |
$11.08 |
$14,260 |
D/D |
(1,287) |
1,209,455 |
|
- |
|
288 Records found
|
|
Page 3 of 12 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|